Beta Drugs Ltd. (BDL) is at the forefront of oncology drug development in India, focusing on innovative New Drug Delivery Systems (NDDS) to enhance patient compliance and minimize dosing errors. The company has developed a diverse portfolio of over 100 stock-keeping units (SKUs) that cater to various cancer types, including solid tumors and hematological conditions. BDL emphasizes the importance of cost-effective solutions, with 99% of its products manufactured in-house, ensuring high quality and accessibility for patients. Their commitment to research and development is evident in their strong pipeline of upcoming products, which aims to provide safe and effective oncology treatments at affordable prices.

The company is also recognized for its robust capabilities in Active Pharmaceutical Ingredient (API) development, which gives it a competitive edge through backward integration. BDL has received WHO-GMP approval for its API plant, positioning it for accelerated growth in both domestic and international markets. Their research initiatives include advanced technologies such as liposomes, nanoparticles, and targeted therapies, with successful commercialization of products like Nanoparticle-Albumin-Bound Paclitaxel and ready-to-use formulations of Docetaxel and Gemcitabine. This focus on innovative drug delivery and a rich pipeline of targeted therapies underscores BDL's commitment to transforming cancer treatment and improving the quality of life for patients.

India

Beta Drugs Ltd. is a dedicated world leader in oncology. BDL is a Global leader in the development of enabling products, scientific knowledge, and technical expertise within a wide range of applications. At Beta DrugsLtd. (BDL.) we are improving both the speed to market of our products and the value of our product introductions to customers. Inspired by a newly-formed breakthrough innovation group, Beta Drugs Ltd. (BDL.) is actively exploring opportunities that stretch business and technology boundaries.

Cancer

Hematologic Diseases

Skin Diseases

SOC 184,Sector-5,Panchkula -134114 Haryana(India), Panchkula, Haryana 134114, IN

BDL - Beta Drugs Ltd.

Company Details